GET A QUOTE

NAMPT (Nicotinamide Phosphoribosyltransferase): A Key Enzyme in NAD+ Biosynthesis and its Role in Metabolic and Aging-Related Diseases

Introduction

Nicotinamide Phosphoribosyltransferase (NAMPT) a player, in generating energy and an important enzyme in the NAD+ biosynthesis pathway is crucial for various cellular activities such as DNA repair and metabolism as well as cell signalling functions in the body connection to different biological functions and diseases including metabolic disorders, to age related brain health decline and cancer concerns.

Biochemical Role in NAD+ Biosynthesis

The enzyme NAMPT plays a role, in transforming nicotinamide and 5 phosphoribosyl I pyrophosphate (PRPP) which’re forms of vitamin B3 into nicotinamide mononucleotide (NM) further converted into NAD+. Maintaining NAD+ levels is essential, for the health and survival of cells; reduced NAMPT expression or function can lower NAD+ levels causing issues and increased susceptibility to stressors. Therefore, the significance of researching NAMPT lies in its potential to impact the availability of NAD+ thereby influencing pathological processes.

Metabolic Diseases: Obesity, Diabetes, and Inflammation

The involvement of NAMPT, in energy metabolism connects it deeply with metabolic issues like obesity and type 2 diabetes. NAMPT is found in concentrations in tissue and comes in both intracellular (known as iNAMPT) and extracellular (referred to as eNAMPT) forms. The intracellular NAMPT mainly plays a role, in producing NAD+ whereas the extracellular NAMPT is released by tissue and has functions associated with inflammation and immune responses.

Research has indicated that higher levels of NAMPT, in tissue are linked to obesity and insulin resistance issues arise when NAMPT activity increases due to obesity as it strives to counter metabolic strain but can also lead to low level inflammation furthermore imbalances in NAMPT levels may worsen the inflammatory mechanisms connected to insulin resistance and type 2 diabetes revealing its twofold impact, in aiding metabolism and triggering metabolic irregularities. Henceforth the regulation of NAMPT has surfaced as a strategy, for treating metabolic conditions through addressing inflammation and maintaining energy balance.

Aging: Neurodegeneration and Longevity

As people get older naturally over time; their NAD+ levels decrease which affects how well cells function and their ability to withstand challenges as they age. Because NAMPT plays a role, in maintaining NAD levels in the body; it is believed to be linked to the aging process and conditions like neurodegeneration. Neurons are especially affected by levels of NAD+ because they depend on it for powering energy activities and, for supporting protective functions through sirtuin proteins and PARPs.

Studies indicate that increasing NAMPT activity may support NAD+ levels, in aging cells and could potentially decelerate aging processes and postpone the development of conditions like Alzheimer’s and Parkinson’s diseases in humans. In experiments involving mice models boosting NAD+ through NAMPT activation has demonstrated enhancement in abilities well as mitochondrial health and lifespan extension. By combating the decline of NAD+ associated with aging through NAMPT activation presents a path, for treatment to encourage healthy aging and deter neurodegenerative conditions.

Therapeutic Potential and Challenges

Studies conducted prior to trials have indicated that NAD+ precursors like NMNs and nicotinamide riboside (NR) can effectively boost NAD+ levels and enhance health outcomes across scenarios by bypass the need for NAMPT in the process of NAD+ biosynthesis. For instance, NMNs supplement has shown encouraging results, in improving glucose metabolism, cognitive functions and muscle strength among individuals.

There are obstacles when it comes to addressing NAMPT, in cancer as certain types of cancer depend heavily upon elevated NAMPT levels to fuel their rapid growth rate. Tumor cells that exhibit heightened NAMPT levels rely significantly upon NAD+ for DNA repair and expansion processes which is why restricting NAMPT could be a promising approach to impede cancer cell growth.\ Medications such as FK866 and other inhibitors of NAMPT are currently being investigated in clinical trials as potential treatments, for cancer yet concerns related to adverse effects and toxicity remain significant hurdles in this path. Furthermore, finding the balance, in inhibiting NAMPT to target cancer cells without harming normal cells is quite a complex task. Hence even though there is potential in targeting NAMPT, for treatment it is crucial to comprehend its functions in tissues and disease situations to create treatments that’re both safe and efficient.

Conclusion

The NAMPT enzyme plays a role, in producing NAD+, which has effects on cell health and overall well-being in relation to metabolism and aging processes as well as disease management strategies. As individuals age and NAD+ levels decrease over time scientists have identified NAMPT as a target for enhancing NAD+ levels to promote health outcomes among aging individuals and those, with metabolic disorders. By regulating metabolism and providing benefits modulating NAMPT activity shows promise in alleviating the impact of conditions associated with NAD+ levels. In cancer treatment targeting NAMPTs various roles, in the body requires consideration as its inhibition could potentially interfere with regular cellular functions. With ongoing research advancements in therapies aiming at NAMPT and NAD+’ biosynthesis may offer effective treatments, for health issues linked to aging and metabolic diseases.

Suitable ELISA Kits

Online Enquiry Form

"*" indicates required fields

Please check mark information required:

TESTIMONIALS arrow icon

Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford